Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Artemether-lumefantrine efficacy and safety for uncomplicated Plasmodium falciparum malaria in Bangladesh
ACTRN12612000935831Phase 4Not yet recruiting
- Sponsor
- Ministry of Health and Family Welfare
- Start
- Sep 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of artemether + lumefantrine in Malaria, sponsored by Ministry of Health and Family Welfare. Primary endpoints: Adequate clinical and parasitological response and Treatment failure. Planned start Sep 2012; status: not yet recruiting.
02
Drugs
artemether + lumefantrine
03
Conditions
Malaria
Beyond the preview
Go deeper on ACTRN12612000935831.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12612000935831.